The sector in Eastern Europe valued at USD 33.65 billion in 2025, reflecting a YoY increase of 11.1%.
Our sector research points to the fact that by 2033, the Eastern Europe Infusion Services Market is likely to hit USD 101.74 billion, with an anticipated CAGR of 14.8% during the forecast window.
Healthcare modernization initiatives and EU structural funding are strengthening oncology infrastructure, increasing infusion chair availability in urban centers across the region.
European Commission regional health investment disclosures indicate continued infrastructure upgrades supporting hospital-based systemic therapy delivery.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]